61 related articles for article (PubMed ID: 16518063)
21. Overexpression of β1 integrin contributes to polarity reversal and a poor prognosis of breast invasive micropapillary carcinoma.
Liu B; Zheng X; Meng F; Han Y; Song Y; Liu F; Li S; Zhang L; Gu F; Zhang X; Fu L
Oncotarget; 2018 Jan; 9(4):4338-4353. PubMed ID: 29435106
[TBL] [Abstract][Full Text] [Related]
22. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
[TBL] [Abstract][Full Text] [Related]
23. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
[TBL] [Abstract][Full Text] [Related]
24. Postoperative radiotherapy for invasive micropapillary carcinoma of the breast: an analysis of Surveillance, Epidemiology, and End Results database.
Wu SG; Zhang WW; Sun JY; Li FY; Chen YX; He ZY
Cancer Manag Res; 2017; 9():453-459. PubMed ID: 29056854
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic study of invasive micropapillary carcinoma of the breast.
Tang SL; Yang JQ; Du ZG; Tan QW; Zhou YT; Zhang D; Lv Q
Oncotarget; 2017 Jun; 8(26):42455-42465. PubMed ID: 28418916
[TBL] [Abstract][Full Text] [Related]
26. Invasive micropapillary component and its clinico-histopathological significance in patients with colorectal cancer.
Jakubowska K; Guzińska-Ustymowicz K; Pryczynicz A
Oncol Lett; 2016 Aug; 12(2):1154-1158. PubMed ID: 27446411
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological features of invasive micropapillary carcinoma of the breast.
Cui ZQ; Feng JH; Zhao YJ
Oncol Lett; 2015 Mar; 9(3):1163-1166. PubMed ID: 25663874
[TBL] [Abstract][Full Text] [Related]
28. Aberrant expression of CD227 is correlated with tumor characteristics and invasiveness of breast carcinoma.
Wang YW; Shi DB; Liu YM; Sun YL; Chen X; Xiang S; Fu Q; Wei JM; Gao P
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1271-81. PubMed ID: 24788565
[TBL] [Abstract][Full Text] [Related]
29. Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression.
Denisov EV; Litviakov NV; Zavyalova MV; Perelmuter VM; Vtorushin SV; Tsyganov MM; Gerashchenko TS; Garbukov EY; Slonimskaya EM; Cherdyntseva NV
Sci Rep; 2014 Apr; 4():4709. PubMed ID: 24736530
[TBL] [Abstract][Full Text] [Related]
30. Protein mislocalization: mechanisms, functions and clinical applications in cancer.
Wang X; Li S
Biochim Biophys Acta; 2014 Aug; 1846(1):13-25. PubMed ID: 24709009
[TBL] [Abstract][Full Text] [Related]
31. HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast.
Doublier S; Belisario DC; Polimeni M; Annaratone L; Riganti C; Allia E; Ghigo D; Bosia A; Sapino A
BMC Cancer; 2012 Jan; 12():4. PubMed ID: 22217342
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of P27 (Kip 1) and MUC1 in papillary transitional cell carcinoma of the urinary bladder.
Abd Elazeez TA; El-Balshy Ael-L; Khalil MM; El-Tabye MM; Abdul-Halim H
Urol Ann; 2011 Jan; 3(1):8-13. PubMed ID: 21346826
[TBL] [Abstract][Full Text] [Related]
33. Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface.
Zhao Q; Guo X; Nash GB; Stone PC; Hilkens J; Rhodes JM; Yu LG
Cancer Res; 2009 Sep; 69(17):6799-806. PubMed ID: 19690136
[TBL] [Abstract][Full Text] [Related]
34. Invasive micropapillary carcinomas arising 42 years after augmentation mammoplasty: a case report and literature review.
Tanaka Y; Morishima I; Kikuchi K
World J Surg Oncol; 2008 Mar; 6():33. PubMed ID: 18341700
[TBL] [Abstract][Full Text] [Related]
35. The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression.
Yu LG
Glycoconj J; 2007 Nov; 24(8):411-20. PubMed ID: 17457671
[TBL] [Abstract][Full Text] [Related]
36. The reversed apical pattern of MUC1 expression is characteristics of invasive micropapillary carcinoma of the breast.
Li YS; Kaneko M; Sakamoto DG; Takeshima Y; Inai K
Breast Cancer; 2006; 13(1):58-63. PubMed ID: 16518063
[TBL] [Abstract][Full Text] [Related]
37. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K
Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874
[TBL] [Abstract][Full Text] [Related]
38. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.
Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L
Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976
[TBL] [Abstract][Full Text] [Related]
39. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
[TBL] [Abstract][Full Text] [Related]
40. Invasive Micropapillary Carcinoma of the Breast: An Update.
Yang YL; Liu BB; Zhang X; Fu L
Arch Pathol Lab Med; 2016 Aug; 140(8):799-805. PubMed ID: 27472238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
